Nuvation Bio (NUVB) Cash & Equivalents (2020 - 2026)
Nuvation Bio's Cash & Equivalents was $258.6 million in Q2 2026, up 4.3% from $247.97 million a year earlier and up 106.2% from the prior quarter.
Powered by 
Analysis
Nuvation Bio (NUVB) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Cash & Equivalents at Nuvation Bio came in at $164.09 million, up 359.3% from FY2024.
- Cash & Equivalents shows a five-year compound annual growth rate of 40.7% (FY2020 to FY2025).
- In earlier years, Cash & Equivalents was $35.72 million in FY2024 (-16.2%), $42.65 million in FY2023 (-57.8%), $101.1 million in FY2022 (-23.7%) and $132.42 million in FY2021 (+345.0%).
- The Q2 2026 figure marks the highest quarterly Cash & Equivalents since Q3 2021.
- Compared with a year earlier, Cash & Equivalents has increased for six straight quarters, with growth averaging 177.9% over the last eight quarters.
- The best year-over-year quarter for Cash & Equivalents over five years was Q2 2025 (growth of 623.3%); the worst was Q1 2022 (a decline of 83.4%).
- Per Business Quant data, NUVB's Cash & Equivalents in the three quarters before Q2 2026 was $125.39 million (Q1 2026), $164.09 million (Q4 2025) and $98.9 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Nuvation Bio | 1.92 Bn | 1.92 Bn | - | 258.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 258.60 Mn |
| Mar 31, 2026 | 125.39 Mn |
| Dec 31, 2025 | 164.09 Mn |
| Sep 30, 2025 | 98.90 Mn |
| Jun 30, 2025 | 247.97 Mn |
| Mar 31, 2025 | 47.98 Mn |
| Dec 31, 2024 | 35.72 Mn |
| Sep 30, 2024 | 30.04 Mn |
| Jun 30, 2024 | 34.29 Mn |
| Mar 31, 2024 | 34.51 Mn |
| Dec 31, 2023 | 42.65 Mn |
| Sep 30, 2023 | 24.40 Mn |
| Jun 30, 2023 | 50.07 Mn |
| Mar 31, 2023 | 30.07 Mn |
| Dec 31, 2022 | 101.10 Mn |
| Sep 30, 2022 | 138.69 Mn |
| Jun 30, 2022 | 102.32 Mn |
| Mar 31, 2022 | 106.21 Mn |
| Dec 31, 2021 | 132.42 Mn |
| Sep 30, 2021 | 344.63 Mn |
API Access
Nuvation Bio Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUVB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "NUVB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=NUVB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();